Delivering answers to patients, sooner
Accelerating Breakthrough Discoveries That Transform Medicine
Pangea Laboratory partners with clinicians, researchers, pharma, and diagnostic developers to bring tests to market that deliver accuracy, speed, and reliability.
Integrated NGS Services Across the Development Spectrum
Pangea is more than a sequencing provider: we’re your partner in advancing healthcare. Our CLIA-certified and CAP-accredited laboratory combines deep scientific expertise, advanced bioinformatics, and scalable infrastructure to help clinicians diagnose with confidence, researchers accelerate discovery, and developers bring breakthrough diagnostics to market.
Pangea's Services
Whether you’re validating a novel biomarker, launching a diagnostic test, or seeking precision clinical insights, our integrated NGS capabilities accelerate your path from research to patient impact.
Clinical Development
Transform innovative research into validated, clinically actionable insights through validated NGS-based diagnostics and precision testing, all within a CLIA/CAP environment.
Reference Lab Services
Empower researchers and clinicians with high-throughput, high-quality sequencing and analysis backed by rigorous quality controls and reproducible standards.
Diagnostic Laboratory
Explore our menu of non-invasive diagnostic testing options that enable earlier detection and improved patient outcomes across oncology and infectious disease assays.
Concept to Commercialization
Pangea is Your
End-to-End Partner
From early-stage feasibility with R&D support to clinical validation and market launch, Pangea Laboratory provides a complete continuum of sequencing, analysis, ongoing quality assessment, and regulatory support. Our approach ensures every phase, from sample collection to bioinformatics reporting, meets the highest standards of accuracy and compliance with scalability.
1
Ideation
2
Development
3
Validation
4
Commercialization
Accredited for Quality. Trusted for Results.
Pangea Laboratory operates under CLIA certification and CAP accreditation, ensuring precision, consistency, and regulatory compliance across all services. These accreditations reflect our commitment to maintaining the highest standards of analytical performance and patient safety in every test we deliver.
Our Offerings
Custom Sequencing Solutions
Tailored assays and bioinformatics pipelines for R&D and clinical translation.
Bladder CARE™
Urine-based accurate bladder cancer testing made simple.
iFOB
Fecal Occult Blood testing for the early detection of colorectal cancer.
PrecisionBIOME™
Bacterial and fungal identification for clinical and industrial applications.
Coming Soon | Q2 2026
Latest News + Insights
Explore how Pangea Laboratory is shaping the future of precision diagnostics, from NGS innovations to clinical assay development.
Partners
Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA
The GA-map® MHI GutHealth is the first microbiome-based diagnostic test providing clinically actionable insights into antibiotic-induced microbiome imbalances. The test has been developed by GA in collaboration…
Pangea in the News
Pangea Laboratory Appoints John Moore as Chief Executive Officer
Partnerships
Pangea Laboratory Partners with Unilabs to Introduce Bladder CARE™ Assay…
Research
Pangea Laboratory Receives FDA Breakthrough Device Designation for the Bladder CARE™ Assay
The Bladder CARE™ Assay measures the methylation levels of three urothelial cancer-specific DNA biomarkers in a single qPCR reaction. It markedly outperforms traditional cytology…